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Background: Knowledge translation (KT) research in long-term care (LTC) is still in its early stages. This protocol
describes the evaluation of a multifaceted, interdisciplinary KT intervention aimed at integrating evidence-based
osteoporosis and fracture prevention strategies into LTC care processes.
Methods and design: The Vitamin D and Osteoporosis Study (ViDOS) is underway in 40 LTC homes (n = 19
intervention, n = 21 control) across Ontario, Canada. The primary objectives of this study are to assess the feasibility
of delivering the KT intervention, and clinically, to increase the percent of LTC residents prescribed ≥800 IU of
vitamin D daily. Eligibility criteria are LTC homes that are serviced by our partner pharmacy provider and have more
than one prescribing physician. The target audience within each LTC home is the Professional Advisory Committee
(PAC), an interdisciplinary team who meets quarterly. The key elements of the intervention are three interactive
educational sessions led by an expert opinion leader, action planning using a quality improvement cycle, audit and
feedback reports, nominated internal champions, and reminders/point-of-care tools. Control homes do not receive
any intervention, however both intervention and control homes received educational materials as part of the
Ontario Osteoporosis Strategy. Primary outcomes are feasibility measures (recruitment, retention, attendance at
educational sessions, action plan items identified and initiated, internal champions identified, performance reports
provided and reviewed), and vitamin D (≥800 IU/daily) prescribing at 6 and 12 months. Secondary outcomes
include the proportion of residents prescribed calcium supplements and osteoporosis medications, and falls and
fractures. Qualitative methods will examine the experience of the LTC team with the KT intervention. Homes are
centrally randomized to intervention and control groups in blocks of variable size using a computer generated
allocation sequence. Randomization is stratified by home size and profit/nonprofit status. Prescribing data retrieval
and analysis are performed by blinded personnel.
Discussion: Our study will contribute to an improved understanding of the feasibility and acceptability of a
multifaceted intervention aimed at translating knowledge to LTC practitioners. Lessons learned from this study will
be valuable in guiding future research and understanding the complexities of translating knowledge in LTC.* Correspondence: kennedyc@hhsc.ca; papaioannou@hhsc.ca
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The field of knowledge translation (KT) attempts to
bridge the gap between the generation of research evi-
dence and the application of this evidence into clinical
practice. KT is commonly defined as ‘a dynamic and it-
erative process that includes synthesis, dissemination,
exchange and ethically-sound application of knowledge’
[1]. Examining the effectiveness of KT strategies across
different contexts, healthcare professions, and target
behaviors is essential [2] if we are to effectively bridge
the gap between research evidence and clinical practice.
To guide decision makers in choosing the best imple-
mentation strategies, rigorous evaluations of KT pro-
grams, including well-designed cluster randomized trials,
are needed [3].
Despite a growing body of KT evidence in acute care
or community settings, KT research in long-term care
(LTC) is still in its early stages [4-6]. Recent LTC initia-
tives have examined the role of organizational context
and/or developed empirically-based theories related to
KT in LTC [7-9]. However, few studies within the LTC
setting have focused on evaluating the effectiveness of
common behaviour change strategies (e.g., audit and
feedback, educational materials, reminders) [10,11], par-
ticularly those involving multifaceted interventions. In a
recent scoping review by Bostrom et al. [5], only 3.6%
(n = 61) of KT studies identified were related to older
adults, and approximately one-half of them were done in
LTC. Problematic is the fact that the majority of these
studies were not targeted at the organizational level, did
not report on system level outcomes, and included only
a single KT strategy (e.g., audit and feedback alone). The
majority of KT interventions, regardless of setting, have
not targeted the entire interdisciplinary team (i.e., physi-
cians, nurses, pharmacists, dietitians, rehabilitation
therapists, and other professionals) [12]. Of the LTC
studies in the Bostrom review [5], 60% did not target
mixed professional groups despite the emphasis on col-
laboration among the disciplines practicing in LTC [13].
Previous multifaceted interventions for interdisciplinary
teams have had some success within the LTC setting
[14,15].
Implementing evidence into practice requires whole
system change [2,16], particularly in the LTC setting
[5,17]. Berta et al. [6] suggest the majority of factors that
may enhance the uptake and use of evidence-based prac-
tices in LTC are organizational and include: a working
culture that facilitates cooperation and knowledgeexchange; standardization of activities; experienced clin-
ical leaders that engage others in the process; and ultim-
ately the incorporation of guidelines that are reinforced
by regulatory bodies. Other factors that enhance imple-
mentation of evidence-based practices in LTC include
strong leadership [17-19], medical directives, and build-
ing best practices recommendations into training materi-
als [20].
Identifying the knowledge-to-action gaps
The topic of our KT intervention is evidence-based
osteoporosis management and fracture prevention strat-
egies [21-27]. Previous research by our team indicates
that many LTC providers are unaware of osteoporosis
and fracture prevention best practices, or have concerns
surrounding diagnosis and treatment in elderly patients
[28,29]. Furthermore, as a recent survey of LTC Medical
Directors and Directors of Nursing documented, barriers
to fracture care were modifiable and could be overcome
through education and changes to local care delivery
systems [30]. Rather than focusing on individual provi-
ders, we propose a model that takes a more collective
approach and emphasizes integrating evidence-based
practices into care processes.
In addition to proper assessment of individuals at high
risk for fracture [21], we are emphasizing the wide-scale
implementation of adequate levels of vitamin D
(≥800 IU/day) because it is a tolerable, low-cost inter-
vention with strong evidence that it can prevent frac-
tures and falls in LTC residents [22,24,26,27,31]. In an
environmental scan of 15 LTC homes we conducted in
2008 (n = 3,132 residents), the overall rate of vitamin D
use was 38% [32], and there was considerable variation
between homes with rates ranging from 11 to 62%. An-
other study [33] we conducted using data collected via
the Resident Assessment Instrument (RAI) 2.0 [34,35]
found similar results.
We developed a multifaceted, interdisciplinary KT
intervention to improve the use of evidence-based osteo-
porosis and fracture prevention practices in LTC homes.
The current report outlines the research design and
protocol for evaluating this KT intervention.
Methods
Study population
The Vitamin D and Osteoporosis (ViDOS) study is cur-
rently underway in 40 LTC homes (19 intervention and
21 control) in Ontario, Canada. In Canada, LTC homes
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are government-regulated facilities designed for indivi-
duals who require onsite nursing care, 24-h supervision,
or personal support [36]. Our recruitment strategy
included LTC homes located in communities of all sizes
and geographical regions across the province of Ontario.
In order to make this study as generalizable as pos-
sible, we have only two facility-level eligibility criteria,
and no patient-level criteria. All LTC homes serviced by
our partner pharmacy provider (Medical Pharmacies
Group Limited) and who have more than one prescrib-
ing physician (at the time of recruitment) were eligible
for recruitment into the study. Medical Pharmacies is a
large pharmacy provider whose services include medica-
tion packaging and distribution, clinical support, and
consulting services to approximately one-third of all
LTC homes in Ontario. Our rationale for excluding LTC
homes with only one treating physician is to maintain
anonymity during the presentation of prescribing reports
at educational sessions. Furthermore, the requirement of
having at least two physicians per home decreases
sample size as it contributes to a lower intracluster cor-
relation coefficient [37].
Aims and objectives
The aim of the ViDOS study is to evaluate the feasibility
and effectiveness of a multifaceted KT intervention to
better integrate evidence-based osteoporosis and fracture
prevention care processes in LTC. In addition to measur-
ing feasibility of the intervention, the primary clinical
objective is to determine if the intervention can increase
the proportion of residents who are prescribed adequate
levels of vitamin D (≥800 IU/day). Secondary objectives
include: to determine if the intervention increases the
prescribing of calcium supplements (≥500 mg/day elem-
ental calcium); to determine if the intervention increases
the prescribing of osteoporosis medications in high-risk
individuals (i.e., documented osteoporosis or prior hip
fracture); to understand the experience of the LTC team
with the intervention and which components were per-
ceived as feasible, acceptable, and effective; and to docu-




Feasibility outcomes are measured at the facility-level
and include (some are only relevant to intervention
homes): the proportion of homes that are recruited and
retained, attendance of Medical Directors and other pro-
fessionals at educational sessions, internal champions
identified, action plan items identified and initiated, per-
formance reports provided and reviewed, falls and
fracture data collection completed. A criterion of ≥80%will be used as the criterion for success on each of these
feasibility measures, with the exception of recruitment.
Other cluster randomized controlled trials (RCTs) in
nursing homes aimed at changing the behaviour of
health professionals have noted recruitment in the 40 to
50% range [38-40], thus our recruitment criterion for
success was 40%.
Clinical
The primary clinical outcomes are the proportion of
residents prescribed vitamin D ≥800 IU/day at 6 and
12 months. The secondary prescribing outcomes are the
proportion of residents prescribed ≥500 mg/day of elem-
ental calcium and the proportion of high risk residents
(i.e., those with a fracture or documented osteoporosis)
prescribed an osteoporosis medication (oral and IV
bisphosphonates, teriparatide, denosumab) at 6 and
12 months. Other secondary outcomes include the num-
ber of falls, hip fracture and all fracture (hip, wrist, spine,
foot, humerus, ribs, clavicle, ankle, other) for the data
collection periods (i.e., three months of falls and fracture
data collected three times during the study, see
Figure 1).
Study design
The ViDOS study is a pilot, cluster RCT [41] comparing
a multifaceted KT intervention with a control group.
The intervention is delivered over a 12-month time
period with data collection extending to 16 months. Al-
location by clusters of LTC homes rather than individual
practitioners was chosen to minimize contamination be-
cause we are targeting interdisciplinary care teams. Be-
cause few other studies have examined this type of
interdisciplinary multifaceted intervention within LTC,
the study was designed as a pilot RCT that emphasizes
feasibility outcomes [42].
Randomization and consent
Stratified block randomization was used to randomly al-
locate LTC homes to the intervention or control arm of
the study (recruitment is now closed). LTC homes were
stratified based on home size and profit/non-profit.
Profit status was taken into consideration because there
is some evidence that the quality of care is higher in
non-profit homes compared to for-profit homes [43-45].
The allocation sequence was computer generated using
nQuery 6.0 software by an off-site research member who
is not involved in the recruitment, enrollment of clus-
ters, or data analysis. Once the appropriate representa-
tive from the home was consented, the independent
member assigned intervention and control groups based
on the sequence and notified the coordinating centre.
Because the homes are not blinded to treatment arms,
the homes were informed of their allocation.
Figure 1 Overview of ViDOS Intervention.
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A multifaceted strategy was chosen based on the consist-
ent evidence that the most successful KT interventions
tend to be interactive and multifaceted [3,10,11,14,15,46-
49]. Systematic reviews of single interventions such as
audit and feedback [50,51], reminders (i.e., tools to aid
decision-making and/or prompt a clinical action) [50],
and opinion leaders [52] have also demonstrated some
effectiveness in changing professional practice. As
described below, we tailored our KT intervention to fit
within the existing operational and organizational cul-
ture of each LTC home.
Target audience
The target audience of the multifaceted intervention is
the Professional Advisory Committee (PAC), an interdis-
ciplinary team [53] that meets quarterly to address resi-
dent care and quality improvement objectives. Members
of the committee typically include: the Administrator,
Medical Director, Director of Care, Consultant Pharma-
cist, Director of Food Services/Dietician, and other nurs-
ing, medical or rehabilitation staff. In addition to PAC
team members, all physicians responsible for the care of
residents within the LTC home are invited to the ses-
sions and are eligible for continuing medical education
credits with the Ontario College of Family Physicians.Development and piloting the intervention
The multifaceted intervention was developed and piloted
in consultation with the PAC team at a local LTC home.
This home identified several procedural and
organizational barriers that we addressed in the final
version of our modules and materials. Learning modules
and materials were built around a toolkit (including
DVD, posters, panel cards, case studies) we developed
for the Ontario Osteoporosis Strategy in LTC (www.
osteoporosislongtermcare.ca [54]) in consultation with
stakeholders. Materials were based on a research synthe-
sis on hip fracture prevention strategies in LTC [22] and
incorporate the 2010 Osteoporosis Canada Clinical Prac-
tice Guidelines [21].
Multifaceted intervention components
As outlined in Figures 1 and 2, intervention homes take
part in three interactive educational sessions, approxi-
mately six months apart. To maximize participation,
these sessions are delivered during a regularly scheduled
meeting of the PAC team. An expert opinion leader
facilitates the first two interactive educational sessions
(approximately 45 to 60 min in length) via webinar tech-
nology, with the study coordinator on-site to facilitate
and distribute materials. A Geriatric Nursing Consultant
leads the third session (approximately 30 min) via
Figure 2 Timeline of Data Collection and Sessions.
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vention (Table 1) are:
1. Expert opinion leader: Utilizing the framework by
Locock et al. [55], we define an expert opinion
leader as ‘a credible authority (often an academic or
consultant) able to explain the evidence and respond
convincingly to challenges and debate.’ Such a
person is distinct from a peer opinion leader who
may be more influential as a role model in daily
practice. The expert opinion leader may be
particularly valuable in the initial stages of
implementing change by ‘translating it into a form
which is acceptable to practitioners and takes
account of their local experience’ [55]. In our study,
the expert opinion leaders are physicians specializing
in osteoporosis and/or geriatrics who are active in
national/international research and guidelines
development.
2. Learning modules: At each session, a learning
module is presented and there is opportunity for
discussion and active participation. In brief, the first
module introduces the study and materials, reviews
best practices for OP management and fracture
prevention, and provides an orientation to action
planning for quality improvement. The second
module emphasizes integration of osteoporosis and
fracture prevention into care processes, reviews
barriers and facilitators, shares strategies from other
intervention homes, and provides a case-study
exercise. The third module reviews accomplishments
and action plan progress, provides information on
hip protectors, identifies internal champions, and
discusses post-study sustainability including an
orientation to resources on our website (www.
osteoporosislongtermcare.ca [54]).
3. DVD: At the first interactive educational session, the
10-minute ‘Meeting the Challenge of Osteoporosisand Fracture Prevention’ DVD is viewed, and a copy
is left at the LTC home so that other staff and
residents/families can be educated (available at www.
osteoporosislongtermcare.ca [54]).
4. Performance reports (audit and feedback):
Aggregate/facility-level data for vitamin D, calcium,
and osteoporosis medication prescribing are
presented in a graphical format at each interactive
educational session. Reports are based on the
previous month’s prescribing and are benchmarked
against other ViDOS intervention homes.
Confidential, individual performance reports are also
provided to each physician.
5. Reminders/Point-of-care tools are distributed and
discussed in the educational sessions. These tools
include the process indicator checklist, treatment alert,
and x-ray requisition stamp (summarized in Table 1).
Tools were developed in consultation with the
pharmacy provider, the Ontario Osteoporosis Strategy
in LTC [54] steering group, and our pilot LTC home.
6. Action planning: This quality improvement
component is built around the plan-do-study-act
(PDSA) cycle [56,57]. In brief, the PDSA process
engages teams in planning and managing change
by breaking goals into manageable chunks, testing
ideas and assessing the results in order to better
monitor the impact of changes. Some LTC homes
may be familiar with the PDSA process from the
‘Long-Term Care Best Practices Initiative’ [12].
After the learning module is presented, PAC
teams discuss and complete an action plan work-
sheet at sessions one and two to address barriers
and identify organizational strategies, process
changes, and specific action items for team
members. Teams work on implementing action
plans and progress is reviewed at the next session.
Strategies generated from sessions are shared with
other LTC homes.
Table 1 Key Components of the Multifaceted ViDOS intervention
Interactive Educational Sessions Presentation of three learning modules that include a summary of best practices, special considerations for
assessing/treating the elderly, key messages, integration of OP/fracture prevention into care processes, and a case




Expert opinion leader leads first and second interactive educational sessions via webinar (with study coordinator
facilitating on-site). A Geriatric Nursing Consultant leads the third interactive educational session via webinar.
DVD A 10-min DVD, ‘Meeting the Challenge of Osteoporosis and Fracture Prevention,’ is viewed at the first interactive
educational session (and a copy left for the team to educate other/new staff members, residents, families). This




Performance reports for vitamin D, calcium, and osteoporosis medications prescribing (aggregated for all
residents in a home) and benchmarked against other ViDOS intervention homes, are presented at each
interactive educational session. Confidential, individual performance reports are also provided to each physician.
Reminders/Point of Care Tools Treatment Alert: A tool used by consultant pharmacists to alert physicians and nurse practitioners to assess and
consider osteoporosis treatment for residents at increased risk for fracture (based on the 2010 Osteoporosis
Canada Clinical Practice Guidelines [21].
X-ray Requisition Stamp: A stamp labeled ‘please rule out vertebral fractures’ to add to chest X-ray requisitions.
Process Indicator Checklist: This tool assists teams with creating internal processes and policies that support and
sustain appropriate prescribing and other osteoporosis and fractures best practices (e.g., admission/quarterly
assessment, diagnoses documentation, ongoing staff education and training).
Action Planning for
Quality Improvement
Discussion/completion of a work-sheet to set specific action items for team members, address barriers and
facilitators, and outline best practices strategies. Homes work on action plans between study sessions.
Internal Champion A PAC team member, such as consultant pharmacist and/or Director of Care, who will network with champions
at other LTC homes (via online forum www.osteoporosislongtermcare.ca [54]) and continue to promote best
practices after the research team has left.
Tool-kit* The tool-kit includes: the 10-min DVD (‘Meeting the Challenge of Osteoporosis and Fracture Prevention’),
informational pocket cards, case studies, and posters. Distributed to all LTC homes as part of the Ontario
Osteoporosis Strategy for LTC.
Osteoporosis Long-Term
Care Website*
The website (www.osteoporosislongtermcare.ca [54]) with an interactive forum for Internal Champions, is
promoted to all LTC homes via the Ontario Osteoporosis Strategy for LTC.
*also provided to all control homes.
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champion is introduced at the first session. By the
end of the study it is anticipated that each home will
have an internally nominated champion, such as the
consultant pharmacist and/or Director of Care.
Champions will be linked by a forum on our website
(www.osteoporosislongtermcare.ca [54]) to facilitate
the ongoing sharing of experiences in implementing
evidence-based changes in processes of care after
the study is completed. Previous studies have found
that the sharing of practical tips among LTC homes
is useful in the implementation of protocols to
improve processes of care [58].
Control homes
Control homes will receive no intervention. After the
intervention homes have completed the study, the con-
trol group will have the option of attending a group
webinar that presents a summary of key messages from
educational modules. They will also be provided with an
opportunity to appoint an internal champion who will
receive post-study resources and updates. All LTC
homes (control and intervention) will also have the op-
portunity to access continuing education throughprofessional meetings (e.g., the Ontario Long-Term Care
Association and the Ontario Long Term Care
Physicians).
LTC osteoporosis toolkit and website
Both control and intervention homes received the LTC
Osteoporosis Toolkit in 2009/2010, which includes a 10-
minute DVD, ‘Meeting the Challenge of Osteoporosis
and Fracture Prevention,’ pocket cards, case studies, and
posters. This toolkit was distributed to all Ontario LTC
homes as part of the provincial government-funded On-
tario Osteoporosis Strategy [59]. The toolkit was devel-
oped to increase awareness of best practices for
osteoporosis and fracture prevention. An introductory
group webinar was available to all LTC homes in On-
tario to introduce the toolkit components. In late 2011,
the Ontario Osteoporosis Strategy for LTC website (www.
osteoporosislongtermcare.ca [54]) was launched and was
promoted in all LTC homes across Ontario.
Post-study sustainability
The final phase of the knowledge to action (KTA) cycle
[60] includes building sustainability mechanisms into the
intervention. It is anticipated that implementation of
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work of each LTC home's internal champion, who will
be provided with updated resources and support by a
forum on our website (www.osteoporosislongtermcare.ca
[54]). This will enable the internal champions to interact
with each other and share successes and challenges. We
will work with our partner pharmacy provider to distrib-
ute prescribing reports to LTC homes one year after
completing the study. This feedback is important given
the high turnover of residents in LTC resulting in a dif-




Feasibility data are collected by the study coordinator.
Other facility-level data being collected include the
number of resident beds, location/type of population
centre (i.e., small, medium, or large population centres
as defined by Statistics Canada) [61], profit status (profit,
non-profit), chain affiliation, and number of treating
physicians at baseline.
Patient-level
Figure 2 provides an overview of the data collection
time-line. De-identified clinical data including demo-
graphic, prescribing, and co-morbidities (from the Medi-
cation Administration Record) are collected from the
pharmacy database by the Director of Systems Services
at Medical Pharmacies (JBS).
Falls and fractures data for every resident are collected
by a LTC staff member at each home for three-month
periods at three times during the study (coinciding with
prescribing data pulls, Figure 2). The information source
used to populate the data collection spreadsheets may
vary by LTC home and sources are documented by the
study coordinator. With the recent wide-scale imple-
mentation of the RAI-2.0 assessments across Ontario
LTC homes [34,35], future studies collecting information
on falls and fracture data will likely use this as a data
source. The RAI-2.0 is a standard assessment using
common methodology and measures and is completed
by trained assessors (typically within 14 days of admis-
sion and then on a quarterly basis).
Qualitative data
After intervention homes have completed the study, in-
dividual interviews will be conducted with selected parti-
cipants to better understand their experience with the
intervention. A research assistant (not affiliated with the
study) will conduct interviews with two PAC team mem-
bers (physician and the Director of Care or consultant
pharmacist) at approximately seven to ten intervention
home sites. Organizational changes to policies andprocesses in intervention homes will be measured by
surveying the Directors of Care regarding the number of
items on the process indicator checklist (Table 1) they
initiated during the study and by examining changes
captured in the action plans.
Trial management
The coordinating centre for the study is at McMaster
University. The study coordinator and research assis-
tants are responsible for submitting research ethics
applications, scheduling of homes, travel arrangements,
developing presentations, obtaining and storing consent
forms, tracking and recording all decisions and transfor-
mations of data made throughout the investigation, and
budgeting. All databases are password protected and
kept on a secure network system.
Data monitoring
No formal comparison between control and intervention
homes will occur until the end of the study when final
analyses are performed. In accordance with Food and
Drug Administration recommendations [62], because
the elderly are considered a ‘potentially fragile popula-
tion,’ a Data and Safety Monitoring Board (DSMB) with
expertise in geriatric medicine and clinical trials research
will meet to monitor ongoing trial processes. There are
no formal stopping rules because the intervention is tar-
geted at health professionals (i.e., does not intervene dir-
ectly with residents) and because the study is primarily
designed to assess feasibility.
Blinding
Study participants, personnel, expert opinion leaders,
and the analyst who provides the audit and feedback
reports are not blinded to home allocation status. The
outcome assessor (JBS) who downloads the demo-
graphic, prescribing, and co-morbidity data and the ana-
lyst who performs the final data analysis will be blinded
to home allocation status. The staff members within
each LTC home who are recording falls and fractures
data are not blinded.
Data analysis
Quantitative analysis
Data from the trial will be analyzed and reported in ac-
cordance with the CONSORT criteria [41,63,64]. The
baseline characteristics will be reported as mean (stand-
ard deviation) or median (minimum, maximum) values
for continuous variables and as counts (percent) for cat-
egorical variables. The primary feasibility outcomes will
be analyzed using descriptive statistics expressed as per-
cent and corresponding 95% confidence intervals (CI).
Our primary analyses will be performed using the
intention-to-treat principle. The generalized estimating
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correlation structure [65], will be used to determine dif-
ferences between groups for the proportion of residents
prescribed vitamin D, calcium and other osteoporosis
medication, and number of fractures or falls. The GEE
method will take into account the clustered nature of
the data, given that residents treated within a LTC home
are expected to be similar or correlated (clustered vari-
able will be the LTC home). For the model, the unit of
analysis will be the resident and the unit of inference will
be the home. There is an increased risk of imbalance at the
resident-level because of the home-level randomization.
Therefore, resident baseline characteristics that will be
included in this analysis are: age, gender, co-morbidities,
and the number of prescribed medications. Unadjusted and
adjusted odds ratios (OR) and corresponding 95% CIs will
be reported. All statistical analyses will be performed using
the SAS/STAT 9.2 software package (SAS Institute Inc.,
Cary, NC, USA) with the criterion for statistical significance
set at α ≤0.05.
Qualitative analysis
All interview data will be audiotaped and then tran-
scribed verbatim by a professional transcriber. Data ana-
lysis will take place concurrently with data collection so
that any emerging themes can be incorporated into the
interview guide and the codebook. To ensure that we
reach informational saturation (all emerging themes are
well understood and supported by ample data), any
topics that are still unclear after completing the inter-
views will be revisited in brief telephone conversations
with interviewees from LTC homes that provided the
least amount of information on those particular topics.
A qualitative data management and retrieval software
program (QSR-Nvivo) [66] will be used to assist with
data organization and retrieval during thematic frame-
work analyses. Both the development of the interview
guides and the thematic analyses applied to the tran-
scripts will be guided by two theories that address the
change process at the individual and organizational
levels: the Theory of Planned Behaviour [67,68], and the
Diffusion of Innovations [69-71].
Sample size
Our sample size was calculated to detect a difference in
the percentage of residents prescribed ≥800 IU/daily
vitamin D at follow-up in the intervention versus control
groups. We assumed an average of 120 residents per
LTC home and that 30% of residents were prescribed
≥800 IU/daily vitamin D at baseline [33]. We postulate a
20% increase in vitamin D prescribing in the interven-
tion group and a 5% increase in the control group (to
account for the potential impact of other province-wide
initiatives such as the Ontario Osteoporosis Strategy forLTC). Based on these assumptions, to detect a 15% dif-
ference in prescribing between the groups with an
intracluster correlation of 0.10 (two-sided test with sig-
nificance = 0.05), a sample size of 2,160 residents from
18 LTC homes in each of the intervention and control
groups is required to achieve 82% power. Factoring in a
potential 10% dropout rate, the recruitment target was
40 LTC homes (20 = intervention, 20 = control).
Ethical considerations
The study was approved by the Hamilton Health
Sciences/McMaster University Faculty of Health Sciences
Research Ethics Board. A representative from the home
provided initial consent prior to randomization, and each
PAC team participant provides written informed consent
at the first educational session.
Discussion
KT research in LTC is still in its early stages [4-6]. Our
project is one of the first RCT studies to examine the ef-
fectiveness and feasibility of a multifaceted, interdiscip-
linary KT intervention in LTC. Given that this is a pilot
RCT, feasibility measures such as recruitment and reten-
tion, attendance at educational sessions by PAC mem-
bers, and use of study materials are important outcomes
for planning future interventions. Furthermore, results
from the upcoming qualitative phase of the pilot study
will provide valuable information about the KT-related
needs of health professionals working in LTC. It will also
assist us in gaining some preliminary data on what may
be the most active ingredients of the complex interven-
tion. A better understanding of these factors will enable
future researchers and care providers to select and tailor
KT strategies that can maximize the uptake and
utilization of evidence in LTC.
Increasing the utilization of available evidence by clini-
cians in daily practice is difficult in any setting, and the
LTC environment presents some additional unique chal-
lenges. Prescribing for the frail elderly is especially chal-
lenging due to the presence of co-morbid illness,
frequently large number of medications, functional im-
pairment, cognitive deficits, and age-associated decline
in renal function [72-74]. The majority of practice guide-
lines do not adequately address the challenges of apply-
ing recommendations to elderly patients, particularly
those with co-morbidities [75]. In addition, the compos-
ition and skills of the nursing staff in LTC are different
than in other sectors because nurse’s aides provide most
of the direct care and their care rituals are often focused
on task completion [19].
Implementing evidence-based practices in LTC is
made more complex by the fact that the physicians are
not typically located at the LTC home. Instead they rely
on the on-site healthcare team to inform and update
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are often registered nurses (as opposed to physicians in
acute or primary care settings) [76], and they assume
greater responsibility for the coordination, decision-
making, and administration of drug-related interventions
[77].
Heavy paperwork and institutional requirements, lim-
ited resource and staffing levels, limited time to imple-
ment protocols, the absence of a learning culture,
entrenched ways of learning and communicating, ‘change
fatigue,’ and high staff turnover are other postulated fac-
tors that inhibit the uptake of evidence-based practices
[6,20,78,79]. In a study of registered nurses working with
the elderly [80], the most commonly noted barriers to
research use were the lack of a cadre of knowledgeable
colleagues with whom they could discuss research issues,
facility-level barriers, the lack of time to read research
studies and the fact that research findings are not readily
available in a single location. These nurses believed that
establishing networks among colleagues, staff, research-
ers, and physicians would enhance the uptake of re-
search evidence.
If the above challenges can be addressed, there are ele-
ments in the LTC environment that also make it condu-
cive to implementing best practices. For example, as
noted by Berta et al. [6] LTC homes are ‘small, structur-
ally flat, and highly reliant on collaborative decision
making’; thus decision makers and staff in LTC may be
more amenable to implementing complex innovations
than in other practice settings.
The design and implementation of our intervention
was founded on the well-known Canadian Institutes of
Health Research Knowledge-to-Action cycle [60]. In this
paper, we describe how our intervention is adapting
knowledge to the local context (LTC homes in Ontario)
and continuously assessing barriers and facilitators to
knowledge use. Despite the importance of tailoring the
intervention based on identified barriers, recent evidence
suggests that many studies do not effectively do this
[81]. We have tailored the intervention to better meet
the needs of LTC care providers by incorporating our
educational sessions within regularly scheduled PAC
team meetings, developing the reminders and point-of-
care tools in partnership with front-line LTC providers,
and engaging staff in identifying their own site-specific
strategies needed to address barriers (e.g., action plan-
ning). We are monitoring knowledge use throughout the
study via the performance reports and action plans com-
pleted on site and evaluating outcomes using quantita-
tive, qualitative, and process measures. Through ongoing
work with internal champions, our partner pharmacy
provider, and our website forum (www.osteoporosislong-
termcare.ca [54]), we have built in sustainability
mechanisms. A Swedish study [18] that examinedwhether nurses who continued continuous quality im-
provement (CQI) activities over several years empha-
sized that supportive leadership and access to
individuals with research expertise were key factors in
sustained evidence-based practice.
Our design elements are also congruent with recom-
mendations from the Nursing Home Quality Initiative
launched in 2002 by the Centers for Medicare and Me-
dicaid Services in the United Stated [58]. Lessons
learned about implementing CQI in LTC included: form-
ing partnerships with LTC stakeholders, engaging physi-
cians and Medical Directors in the CQI process,
teaching CQI principles to all LTC staff, facilitating the
exchange of successful strategies and practical tips
among LTC homes, and providing one-on-one assistance
to LTC staff and administrators. Frequent contact with
and involvement of the entire CQI team were identified
as essential to overcoming problems stemming from
high staff turnover and heavy workload demands on
Administrators and Directors of Nursing [58]. ViDOS
has taken this advice and worked closely with the entire
PAC team, including Medical Directors, to develop and
update action plans to improve bone health of LTC
residents.
Certainly one of the frequently asked questions regard-
ing multifaceted interventions is: which components of
the ‘black-box’ are most effective? Although we cannot
answer this question quantitatively, we will attempt to
address this issue in the qualitative phase of the study by
asking participants how effective they perceived the vari-
ous elements of the ViDOS intervention to be, and what
individual and organizational factors they believe facili-
tated or inhibited the change process.
The lessons learned from this pilot RCT will be helpful
when planning future KT research on other health issues
in LTC settings. This includes insights on the KT
process (e.g., recruitment and retention of leaders in
innovation), resources (time and budget issues), manage-
ment (personnel and data management issues), and sci-
entific evidence (effect sizes, intracluster correlation)
[42]. It is anticipated the final results of this study will
be presented in 2013.
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